Nabekura Tsukasa
- Conference, etc.
- The role of CD155, a novel co-stimulatory molecule in CD4+ T cells, in contact dermatitis
Yumi Kanemaru; Yuichi Takahashi; Yinan Wang; Aya Yoshioka; Ts...
第40回 日本免疫学会総会・学術集会/2011-11 - A critical role of DNAM-1 in the development of acute graft-versus-host disease
Nabekura Tsukasa
The 5th Tsukuba Medical Science Research Meeting/2011-01 - Identification and characterization of the poliovirus receptor(CD155)as a novel co-stimulatory molecule in CD4+ T cells.
Yamashita Y; Wang Y; Yoshioka A; Nabekura T; Tahara-Hanao...
第14回国際免疫学会議/2010-08-27 - Identification and characterization of the poliovirus receptor(CD155)as a novel co-stimulatory molecule in CD4+ T cells.
Yamashita Y; Wang Y; Yoshioka A; Nabekura T; Tahara-Hanao...
第14回国際免疫学会議/2010-08-26 - Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
Nabekura Tsukasa
The 2nd Society of Immunotherapy for Hematological Malignancies/2010-08 - A critical role of DNAM-1 in the development of acute graft-versus-host diseas
Nabekura Tsukasa
The 14th International Congress of Immunology/2010-08 - DNAM-1は移植片対宿主病の発症において重要な役割を果たす
鍋倉 宰; 渋谷 和子; 竹中 江里; 渋谷 彰
第20回Kyoto T Cell Conference/2010-06-05 - A critical role of DNAM-1 in the development of acute graft-versus-host disease
Nabekura Tsukasa
The Keystone Symposia on Molecular and Cellular Biology (Lymphocyte Activation)/2010-02 - Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
Nabekura Tsukasa
The 39th Annual Meeting of the Japanese Society of Immunology/2009-12 - Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
Nabekura Tsukasa
The 71st Annual Meeting of the Japanese Society of Hematology/2009-10 - Induction of tumor-specific T cells by inoculation of genetically modified dendritic cells
Nabekura Tsukasa
The 18th Kyoto T Cell Conference/2008-06 - An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
Nabekura Tsukasa
The 37th Annual Meeting of the Japanese Society of Immunology/2007-11 - Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura Tsukasa
The 13th Annual Meeting of the Japan Society of Gene Therapy/2007-06 - Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura Tsukasa
The 36th Annual Meeting of the Japanese Society of Immunology/2006-12 - Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura Tsukasa
The 12th Annual Meeting of the Japan Society of Gene Therapy/2006-08 - Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura Tsukasa
The 35th Annual Meeting of the Japanese Society for Immunology/2005-12 - Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura Tsukasa
The 11th Annual Meeting of the Japan Society of Gene Therapy/2005-07 - Potent cancer immunotherapy with dendritic cells generated from genetically modified hematopoietic stem cells
Nabekura Tsukasa
The 7th Annual Meeting of the American Society of Gene Therapy/2004-06 - Establishment of a novel cancer immunotherapy with genetically modified dendritic cells.
Nabekura Tsukasa
The 33rd Annual Meeting of the Japanese Society for Immunology/2003-12
- The role of CD155, a novel co-stimulatory molecule in CD4+ T cells, in contact dermatitis